ArticleBioMed research international2015

Genetic Polymorphisms of IL-17F and TRAF3IP2 Could Be Predictive Factors of the Long-Term Effect of Infliximab against Crohn's Disease.

Shigetoshi Urabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.